Prothena

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$4.32-$17.66
Market Cap
$559.8M
Shares Short
4M

Financials

See more
Revenue (12 Mos)
$11.7M
Revenue Growth (YoY)
149%
Gross Profit (12 Mos)
-$158.6M
Diluted EPS
-$5.20

News

See more

Yahoo Finance • 19 days ago

Prothena Reports Third Quarter 2025 Financial Results and Business Highlights

Yahoo Finance • last month

Prothena Corporation plc (PRTA): A Bull Case Theory

Yahoo Finance • 2 months ago

Bristol Myers Alzheimer's Drug Earns FDA Fast Track

Yahoo Finance • 2 months ago

Prothena’s Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986446 (PRX005), an Anti-MTBR-Tau-Targeting Antibody, for the Treatment of Alzheimer’s Disease

About

CEO
Dr. Gene G. Kinney Ph.D.
CFO
Mr. Tran B. Nguyen M.B.A.
Address
77 Sir John Rogerson?s Quay, Dublin, Ireland, D02 VK60
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
163